Results for “ ”

Entry Author Date Location
CRISPR Update Could Make Gene Edits Easier, Discoverers Say 09/25/15 Boston
Stemina, Eyeing Boston VC, Launches Large Autism Diagnostic Study 09/24/15 Wisconsin
Shkreli Implodes And Provides Hillary A Perfect Medicare Moment 09/23/15 National
Agenda Posted for Boston’s Life Science Disruptors on Sept. 30 09/22/15 Boston
With Termeer Aboard, Artax Tries New Attack On Autoimmune Disease 09/22/15 Boston
Announcing Xconomy Healthcare Summit—Nov. 17 at Broad Institute 09/21/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
With $75M, Deciphera Fuels Push For Cancer Drugs—And a Future IPO 09/21/15 Boston
Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy 09/18/15 National
Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients 09/17/15 Boston
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
Celgene Cozies up to Nurix With $150M Drug Development Deal 09/16/15 San Francisco
Obama Nominates Duke Veteran Rob Califf To Lead FDA 09/15/15 National
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
Qualcomm Buys Capsule to Unite Health Data Across Hospital & Home 09/14/15 San Diego
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue 09/14/15 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
IBM Watson Health Taps Ex-Philips CEO as GM, Touts New Partners 09/10/15 Boston
CureVac Opens up an mRNA Hub in Moderna’s Cambridge Backyard 09/10/15 Boston
Stealthy Boston-Area Startup DOTS Devices Raises $8M 09/09/15 Boston
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug 09/09/15 Boston
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase 09/08/15 Boston
GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding 09/08/15 San Francisco
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Sage Points to Tremor Data to Back Up “De-Risked” Neuro Drug Plan 09/03/15 Boston
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer 09/01/15 Boston
Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ 09/01/15 Boston
Page 3 of 102 « previous page · next page »